These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2353755)

  • 1. [Physiopathogeny of dermatomyositis and polymyositis].
    Chérin P; Herson S; Godeau P
    Ann Med Interne (Paris); 1990; 141(2):156-9. PubMed ID: 2353755
    [No Abstract]   [Full Text] [Related]  

  • 2. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ; Will RK; Peter JB; Garlepp MJ; Dawkins RL
    J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic findings in dermatomyositis. Observations on 20 cases and a review of the literature].
    Giannetti A; Saggiorato F
    G Ital Dermatol Venereol; 1985; 120(1):19-28. PubMed ID: 3891597
    [No Abstract]   [Full Text] [Related]  

  • 4. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
    Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological aspects of polymyositis].
    Takayanagi T; Honda H
    No To Shinkei; 1983 Jun; 35(6):525-33. PubMed ID: 6354219
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D; Rovenský J; Cebecauer L; Hajzok O
    Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
    J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dermatopolymyositis and D-penicillamine: value of the search for anti-JO1 antibodies].
    Koeger AC; Oberlin F; Rozenberg S; Bourgeois P
    Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):774. PubMed ID: 1306601
    [No Abstract]   [Full Text] [Related]  

  • 9. Dermatomyositis and nasopharyngeal carcinoma. A case report and innunological investigation.
    Deng JS; Chang CM; Lu YC; Hsieh T
    Taiwan Yi Xue Hui Za Zhi; 1971 Dec; 70(12):707-12. PubMed ID: 4950990
    [No Abstract]   [Full Text] [Related]  

  • 10. [Polymyositis induced by D-penicillamine treatment of rheumatoid arthritis: apropos of 2 cases with antinuclear antibodies].
    Masson CJ; Ménard HA; Audran M; Renier JC; Lussier A; Myhal DM
    Union Med Can; 1986 Dec; 115(12):855-9. PubMed ID: 3492802
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis.
    Roux S; Seelig HP; Meyer O
    J Rheumatol; 1998 Feb; 25(2):395-6. PubMed ID: 9489847
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental polymyositis.
    Manghani D; Sloper JC
    J Pathol; 1973 Jan; 109(1):Pxii. PubMed ID: 4719761
    [No Abstract]   [Full Text] [Related]  

  • 13. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 14. [Occurrence of autoantibodies and the clinical course of mixed connective tissue disease, systemic scleroderma, dermatomyositis, polymyositis and Sjögren's syndrome].
    Prokop J; Zietkiewicz E; Słomski R
    Przegl Dermatol; 1986; 73(4):327-31. PubMed ID: 3333867
    [No Abstract]   [Full Text] [Related]  

  • 15. Dermatomyositis occurring during psoralen A (PUVA) therapy.
    Sinoway PA; Davidson CL; Callen JP
    J Rheumatol; 1994 Feb; 21(2):353-6. PubMed ID: 8182650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immunity in polymyositis/dermatomyositis.
    Ytterberg SR
    Mt Sinai J Med; 1988 Nov; 55(6):494-500. PubMed ID: 3068538
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antinuclear and anticytoplasmic antibodies in 24 cases of dermatomyositis. Value of western blotting].
    Meyer O; Aeschlimann A; Bourgeois P; Belmatoug N; Palazzo E; Haim T; Kahn MF
    Ann Med Interne (Paris); 1989; 140(6):449-52. PubMed ID: 2696398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Juvenile dermatomyositis. Immunologic and clinical overlapping with systemic lupus erythematosus].
    Wollina U; Roth H; Grübner I
    Dermatol Monatsschr; 1985; 171(10):634-40. PubMed ID: 3877649
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and serologic features of patients with polymyositis or dermatomyositis.
    Holden DJ; Brownell AK; Fritzler MJ
    Can Med Assoc J; 1985 Mar; 132(6):649-53. PubMed ID: 3872156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic lupus erythematosus, polymyositis and toxoplasma antibodies].
    Hamza M; Maalej A; Ayed K; Moalla M; Ben Rachid M; Ben Ayed H
    Sem Hop; 1983 Jan; 59(1):43-6. PubMed ID: 6297086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.